AEMD (Aethlon Medical) Cyclically Adjusted PB Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AEMD Aethlon Medical Inc AEMD
19 GF Score
Price $6.32
! 2 Warning Signs
View Full Analysis

What is Aethlon Medical Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aethlon Medical  (NAS:AEMD) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Aethlon Medical Cyclically Adjusted PB Ratio Related Terms


Aethlon Medical Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Aethlon Medical's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aethlon Medical Cyclically Adjusted PB Ratio Chart

Aethlon Medical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.08 0.02 0.00

Aethlon Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.00 0.00 0.00

AEMD vs PFSA, LUDG, NUMD: Cyclically Adjusted PB Ratio Comparison

For the Medical Devices subindustry, Aethlon Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aethlon Medical Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aethlon Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aethlon Medical's Cyclically Adjusted PB Ratio falls into.


AEMD
19GF Score
Aethlon Medical Inc AEMD
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aethlon Medical Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Aethlon Medical's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Aethlon Medical's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=10.891/333.9520*333.9520
=10.891

Current CPI (Jun. 2026) = 333.9520.

Aethlon Medical Quarterly Data

Book Value per Share CPI Adj_Book
201609 -1,037.780 241.428 -1,435.495
201612 8.348 241.432 11.547
201703 4,060.972 243.801 5,562.609
201706 -6,426.906 244.955 -8,761.928
201709 121.392 246.819 164.246
201712 17,973.391 246.524 24,347.528
201803 20,404.601 249.554 27,305.342
201806 17,265.189 251.989 22,880.937
201809 13,496.027 252.439 17,853.918
201812 10,238.496 251.233 13,609.543
201903 7,258.622 254.202 9,535.847
201906 3,197.911 256.143 4,169.346
201909 61.834 256.759 80.424
201912 3,183.673 256.974 4,137.360
202003 3,961.677 258.115 5,125.661
202006 5,032.845 257.797 6,519.582
202009 4,489.172 260.280 5,759.828
202012 3,772.562 260.474 4,836.777
202103 3,059.501 264.877 3,857.362
202106 6,430.553 271.696 7,904.040
202109 5,949.053 274.310 7,242.529
202112 5,337.239 278.802 6,393.002
202203 4,407.866 287.504 5,119.983
202206 3,731.513 296.311 4,205.535
202209 3,463.440 296.808 3,896.872
202212 3,009.088 296.797 3,385.785
202303 2,620.721 301.836 2,899.571
202306 2,111.331 305.109 2,310.922
202309 1,655.792 307.789 1,796.539
202312 1,172.524 306.746 1,276.518
202403 877.100 312.332 937.814
202406 250.051 314.175 265.791
202409 172.443 315.301 182.644
202412 123.951 315.605 131.157
202503 127.601 319.799 133.248
202506 65.869 322.561 68.195
202509 37.737 324.800 38.800
202512 34.489 324.054 35.542
202603 15.557 330.213 15.733
202606 10.891 333.952 10.891

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aethlon Medical Business Description

Address 11555 Sorrento Valley Road, Suite 203, San Diego, CA, USA, 92121
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
19GF Score

Get the complete analysis for AEMD

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.32
Price